P2Y2 receptor transcription is increased by NF-κB and stimulates cyclooxygenase-2 expression and PGE2 released by intestinal epithelial cells

Journal of Immunology

Volumn 183, Issue 7, 2009, Pages 4521-4529

  Degagné, Emilie ^a   Grbic, Djordje M ^a   Dupuis, Andrée Anne ^a   Lavoie, Elise G ^b   Langlois, Christine ^a   Jain, Nishant ^c   Weisman, Gary A ^c   Sévigny, Jean ^b   Gendron, Fernand Pierre ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; HISTONE H3; HISTONE H4; I KAPPA B; PROSTAGLANDIN E2; PURINERGIC P2Y2 RECEPTOR; SYNAPTOTAGMIN I; AUTACOID; PURINERGIC P2 RECEPTOR; TRANSCRIPTION FACTOR RELA;

ACETYLATION; ANIMAL CELL; ARTICLE; CELL STRAIN CACO 2; CHROMATIN; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INFLAMMATION; INTESTINE EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL LINE; CYTOLOGY; ENZYMOLOGY; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; PATHOLOGY; PHYSIOLOGY; SECRETION; UPREGULATION;

ANIMALS; CACO-2 CELLS; CELL LINE; CYCLOOXYGENASE 2; DINOPROSTONE; HUMANS; INFLAMMATION MEDIATORS; INTESTINAL MUCOSA; PROMOTER REGIONS, GENETIC; RATS; RECEPTORS, PURINERGIC P2; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 70449698535     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803977     Document Type: Article

References (57)

1. Wallace, J. L., and P. R. Devchand. 2005. Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense. Br. J. Pharmacol. 145: 275-282. (Pubitemid 40896072)
2. McKay, D. M. 2005. Good bug, bad bug: in the case of enteric inflammatory disease does the epithelium decide? Mem. Inst. Oswaldo Cruz 100(Suppl. 1): 205-210.
3. Muller, C. A., I. B. Autenrieth, and A. Peschel. 2005. Innate defenses of the intestinal epithelial barrier. Cell Mol. Life Sci. 62: 1297-1307.
4. Dunne, C. 2001. Adaptation of bacteria to the intestinal niche: probiotics and gut disorder. Inflamm. Bowel Dis. 7: 136-145. (Pubitemid 32998502)
5. Dionne, S., F. M. Ruemmele, and E. G. Seidman. 1999. Immunopathogenesis of inflammatory bowel disease: role of cytokines and immune cell-enterocyte interactions. Nestle Nutr. Workshop Ser. Clin. Perform. Programme 2: 41-61.
6. Panja, A., E. Siden, and L. Mayer. 1995. Synthesis and regulation of accessory/proinflammatory cytokines by intestinal epithelial cells. Clin. Exp. Immunol. 100: 298-305.
7. Bours, M. J., E. L. Swennen, F. Di Virgilio, B. N. Cronstein, and P. C. Dagnelie. 2006. Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 112: 358-404.
8. Brunschweiger, A., and C. E. Muller. 2006. P2 receptors activated by uracil nucleotides: an update. Curr. Med. Chem. 13: 289-312.
9. 7 nucleotide receptors that mediate neuroinflammatory responses in astrocytes and microglial cells. Biomed. Res. 14: 47-61.
10. 6 receptor on epithelial cells and the release of CXC chemokine ligand 8 by UDP. J. Immunol. 180: 2659-2668.
11. Oppenheim, J. J., and D. Yang. 2005. Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 17: 359-365.
12. Ivanova, E. P., Y. V. Alexeeva, D. K. Pham, J. P. Wright, and D. V. Nicolau. 2006. ATP level variations in heterotrophic bacteria during attachment on hydrophilic and hydrophobic surfaces. Int. Microbiol. 9: 37-46.
13. Kunzli, B. M., P. O. Berberat, T. Giese, E. Csizmadia, E. Kaczmarek, C. Baker, I. Halaceli, M. W. Buchler, H. Friess, and S. C. Robson. 2007. Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G223-G230.
14. 2 nucleotide receptor up-regulation in submandibular gland cells from the NOD.B10 mouse model of Sjögren's syndrome. Arch. Oral Biol. 50: 533-540.
15. 2 nucleotide receptors mediate uridine 5′-triphosphate-induced intimal hyperplasia in collared rabbit carotid arteries. Circulation 106: 2720-2726.
16. Baker, O. J., J. M. Camden, R. S. Redman, J. E. Jones, C. I. Seye, L. Erb, and G. A. Weisman. 2008. Proinflammatory cytokines tumor necrosis factor-α and interferon-γ alter tight junction structure and function in the rat parotid gland Par-C10 cell line. Am. J. Physiol. Cell. Physiol. 295: C1191-C1201.
17. 2 nucleotide receptor activation up-regulates vascular cell adhesion molecule- 1 [corrected] expression and enhances lymphocyte adherence to a human submandibular gland cell line. Mol. Immunol. 45: 65-75.
18. 2 nucleotide receptor mediates UTP-induced vascular cell adhesion molecule-1 expression in coronary artery endothelial cells. J. Biol. Chem. 278: 24960-24965.
19. Braun, M., K. Lelieur, and M. Kietzmann. 2006. Purinergic substances promote murine keratinocyte proliferation and enhance impaired wound healing in mice. Wound Repair Regen. 14: 152-161.
20. 2 nucleotide receptor inhibits human keratinocyte spreading and migration. FASEB J. 21: 4047-4058.
21. 4 receptors in the regulation of intestinal chloride secretion. Br. J. Pharmacol. 146: 364-369.
22. 2 receptor in rat distal colonic mucosa. Pflugers Arch. 436: 712-716.
23. 4 receptors in mouse colon. J. Physiol. 564: 269-279.
24. 4- purinergic receptors are over-expressed in human colon cancer. Auton. Autacoid Pharmacol. 27: 79-84.
25. Schreiber, S., S. Nikolaus, and J. Hampe. 1998. Activation of nuclear factor κB inflammatory bowel disease. Gut 42: 477-484. (Pubitemid 28186562)
26. 2 nucleotide receptor mediates vascular cell adhesion molecule-1 expression through interaction with VEGF receptor-2 (KDR/Flk-1). J. Biol. Chem. 279: 35679-35686.
27. Gendron, F. P., S. Mongrain, P. Laprise, S. McMahon, C. M. Dubois, M. Blais, C. Asselin, and N. Rivard. 2006. The CDX2 transcription factor regulates furin expression during intestinal epithelial cell differentiation. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G310-G318.
28. Araki, Y., H. Sugihara, and T. Hattori. 2006. In vitro effects of dextran sulfate sodium on a Caco-2 cell line and plausible mechanisms for dextran sulfate sodium- induced colitis. Oncol. Rep. 16: 1357-1362.
29. Francoeur, C., F. Escaffit, P. H. Vachon, and J. F. Beaulieu. 2004. Proinflammatory cytokines TNF-α and IFN-γ alter laminin expression under an apoptosis-independent mechanism in human intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G592-G598.
30. Laniel, M. A., A. Beliveau, and S. L. Guerin. 2001. Electrophoretic mobility shift assays for the analysis of DNA-protein interactions. Methods Mol. Biol. 148: 13-30.
31. Strausberg, R. L., E. A. Feingold, L. H. Grouse, J. G. Derge, R. D. Klausner, F. S. Collins, L. Wagner, C. M. Shenmen, G. D. Schuler, S. F. Altschul, et al. 2002. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. USA 99: 16899-16903.
32. Suzuki, Y., H. Taira, T. Tsunoda, J. Mizushima-Sugano, J. Sese, H. Hata, T. Ota, T. Isogai, T. Tanaka, S. Morishita, et al. 2001. Diverse transcriptional initiation revealed by fine, large-scale mapping of mRNA start sites. EMBO Rep. 2: 388-393.
33. Yang, C., E. Bolotin, T. Jiang, F. M. Sladek, and E. Martinez. 2007. Prevalence of the initiator over the TATA box in human and yeast genes and identification of DNA motifs enriched in human TATA-less core promoters. Gene 389: 52-65.
34. Volloch, V., B. Schweitzer, and S. Rits. 1994. Ligation-mediated amplification of RNA from murine erythroid cells reveals a novel class of β globin mRNA with an extended 5′-untranslated region. Nucleic Acids Res. 22: 2507-2511.
35. Beilina, A., F. Tassone, P. H. Schwartz, P. Sahota, and P. J. Hagerman. 2004. Redistribution of transcription start sites within the FMR1 promoter region with expansion of the downstream CGG-repeat element. Hum. Mol. Genet. 13: 543-549. (Pubitemid 38313213)
36. Li, B., M. Carey, and J. L. Workman. 2007. The role of chromatin during transcription. Cell 128: 707-719.
37. Quina, A. S., M. Buschbeck, and L. Di Croce. 2006. Chromatin structure and epigenetics. Biochem. Pharmacol. 72: 1563-1569.
38. Miao, F., I. G. Gonzalo, L. Lanting, and R. Natarajan. 2004. In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J. Biol. Chem. 279: 18091-18097. (Pubitemid 38560579)
39. Sun, Z., and R. Andersson. 2002. NF-κB activation and inhibition: a review. Shock 18: 99-106.
40. Chen, L. F., and W. C. Greene. 2003. Regulation of distinct biological activities of the NF-κB transcription factor complex by acetylation. J. Mol. Med. 81: 549-557.
41. Davie, J. R., and V. A. Spencer. 1999. Control of histone modifications. J. Cell. Biochem. Suppl. 32-33: 141-148.
42. Cohn, S. M., S. Schloemann, T. Tessner, K. Seibert, and W. F. Stenson. 1997. Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. J. Clin. Invest. 99: 1367-1379.
43. Singer, I. I., D. W. Kawka, S. Schloemann, T. Tessner, T. Riehl, and W. F. Stenson. 1998. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115: 297-306. (Pubitemid 28363422)
44. 2 in experimental inflammatory bowel disease is mediated through the IL-23→IL-17 axis. J. Immunol. 178: 8138-8147.
45. Stenson, W. F. 2007. Prostaglandins and epithelial response to injury. Curr. Opin. Gastroenterol. 23: 107-110.
46. 2 production in human A549 alveolar type II epithelial cells. Eur. J. Pharmacol. 566: 167-171.
47. 2 by IMCD is altered in hydrated and dehydrated rats: relevance to AVP-independent regulation of IMCD function. Am. J. Physiol. Renal Physiol. 289: F585-F592.
48. 2 by rat inner medullary collecting duct preparations. Am. J. Physiol. Renal Physiol. 285: F711-F721.
49. Jin, J., V. R. Dasari, F. D. Sistare, and S. P. Kunapuli. 1998. Distribution of P2Y receptor subtypes on haematopoietic cells. Br. J. Pharmacol. 123: 789-794. (Pubitemid 28085377)
50. 2 nucleotide receptor expression in the duct-ligated rat submandibular gland. Am. J. Physiol. Cell. Physiol. 279: C286-C294.
51. Seye, C. I., A. P. Gadeau, D. Daret, F. Dupuch, P. Alzieu, L. Capron, and C. Desgranges. 1997. Overexpression of P2Y2 purinoceptor in intimal lesions of the rat aorta. Arterioscler. Thromb. Vasc. Biol. 17: 3602-3610.
52. 2 receptor. J. Neurochem. 109: 1300-1310.
53. Spencer, V. A., and J. R. Davie. 1999. Role of covalent modifications of histones in regulating gene expression. Gene 240: 1-12.
54. Zhong, H., M. J. May, E. Jimi, and S. Ghosh. 2002. The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC-1. Mol. Cell 9: 625-636. (Pubitemid 34273792)
55. Pugh, B. F., and R. Tjian. 1991. Transcription from a TATA-less promoter requires a multisubunit TFIID complex. Genes Dev. 5: 1935-1945.
56. Wallace, J. L. 2006. COX-2: a pivotal enzyme in mucosal protection and resolution of inflammation. Sci. World J. 6: 577-588.
57. 2 is an early anti-inflammatory signal in experimental colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 279: G238-G244.